Skip to main content
. 2016 Jan 27;6:19520. doi: 10.1038/srep19520

Table 1. Characteristics of Cohort Studies of Hyperuricemia and Coronary Heart Disease.

Reference, publication (yr) Country/Population Participants (% males) Age range or mean (yr) Follow-up (yr) Hyperuricemia Assessment (mg/dl) No. of total CHD cases Outcome Ascertainment Variables controlled Study quality
CHD INCIDENCE
Freedman et al.31 1995 United States 5421 (46) 25–74 13.5 7 (C); per 1 mg/dl increase 403 (M) 286 (F) Based on hospital records and death certificates Age, race, cholesterol, DBP, smoking, alcohol, education level, and use of antihypertensive and diuretic meds 9
Goldberg et al.32 1995 United States 2710 (100) 55–64 23 6.8 (M) 352 (M) Based on autopy reports and/or medical records such as EKGs and cardiac enzymes Age 8
Liese et al.33 1999 Germany/European 960 (100) 45–64 8 6.3 (M) 55 (M) Based on medical records such as clinical symptoms, EKGs, cardiac enzymes, and autopsy reports Age, alcohol, cholesterol/HDL ratio, HTN, smoking, BMI, education, and use of diuretics 9
Culleton et al.34 1999 United States 6763 (45.5) 47 ± 15 17.4 6.8 (M) 6.3 (F) 394 (M) 223 (F) Based on medical records such as clinical symptoms, EKGs, and cardiac enzymes Age, BMI, SBP, use of antihypertensive and diuretic meds, DM, cholesterol, alcohol, smoking, LVH, and menopausal status 9
Moriarity et al.35 2000 United States 13504 (43.7) 45–64 8 7.6 (M); 6.3 (F) 264 (M) 128 (F) Based on medical records such as clinical symptoms, EKGs, and cardiac enzymes, and data on death certificates Age, race, ARIC center, smoking, LDL, SBP, BMI, HDL, DM, waist/hip ratio, protein, TG, alcohol, and antihypertensive meds 9
Puddu et al.36 2001 Italy/European 2469 (45.2) 35–74 6 7.3 (C) 68 (M) 41 (F) Based on paper/phone questionnaires, EKGs, and medical records Age, sex, SBP, cholesterol, DM, smoking, and BMI 9
Chien et al.37 2005 China/Asian 3602 (47) ≥35 8.5 7.7 (M); 6.6 (F) 86 Based on death certificates and hospital records Age, SBP, BMI, DM, cholesterol, smoking, and alcohol 9
Wheeler et al.10 2005 Iceland/European 6042 (70.3) 56 ± 9 17.5 5.7 (M); 4.7 (F) 2080 Based on questionnaires, EKGs, and medical records Age, smoking, SBP, cholesterol, BMI, TG, FEV1, and DM 9
Bos et al.38 2006 Netherlands/European 4385 (35.4) ≥55 8.4 6.4 (M); 5.4 (F); 6.5 (C) 515 Based on ICD-9 codes on medical records Age, sex, SBP, cholesterol, HDL, DM, smoking, diuretic use, and waist/hip ratio 9
Krishnan et al.39 2006 United States 12866 (100) 46 ± 6 6.5 7.0 (M) 1108 (M) Based on review of medical records such as EKGs and CABG surgery Age, BP, cholesterol, serum creatinine, DM, smoking, BMI, family history of AMI, alcohol, aspirin and diuretic use 9
Baba et al.40 2007 Japan/Asian 2024 (38.3 62 ± 9.9 (M); 63.2 ± 8.4 (W) 8 7.0 (C) 49 Based on self-reports, EKGs, and medical records Age, sex, smoking, alcohol, DM, and fatty liver 9
Meisinger et al.41 2008 Germany/European 3424 (100) 45–74 11.7 6.6 (M) 297 (M) Based on the population based data from coronary event registry and death certificates Age, smoking, alcohol, physical activity, HTN, BMI, DM, CRP dyslipidemia, creatinine, and diuretic use 9
Kavousi et al.13 2012 Netherlands/European 5933 (40.6) 69.1 ± 8.5 6.8 5.0 (C) 347 Based on ICD-9 codes on medical records Age, sex, BMI, SBP, treatment of HTN, total and HDL cholesterol levels, use of lipid-lowering medication, smoking, and DM 9
Storhaug et al.14 2013 Norway/European 5700 (47.3) 55–75 12.5 6.0 (M); 5.7(F); per 1.5 mg/dl increase 659 Based on death certificates and hospital records Age, BMI, SBP/DBP, HDL/TC, use of diuretics and other antihypertensive meds, smoking, physical activity, and renal factors 9
CHD MORTALITY
Levine et al.42 1989 United States 4825 (0) 45–64 11.5 Per 1 mg/dl increase 23 (F) Based on ICD-8 codes on death certificates; autopsy and hospital reports if available Age, weight, smoking, DBP, cholesterol, and antihypertensive meds 9
Fang et al.43 2000 United States 5926 (45.6) 25–74 16.4 7.0 (M); 5.6 (F); Per 1 mg/dl increase 222 (M); 172 (F) Based on ICD-9 codes on death certificates; hospital records if available Age, cholesterol, race, BMI, smoking, alcohol, HTN, DM, and sex 9
Tomita et al.44 2000 Japan/Asian 49413 (100) 25–60 5.4 6.5 (M) 85 (M) Based on ICD-9 codes on health and pension records Age 8
Eboule et al.45 2001 Belgium/European 9701 (53.9) 25–74 10 7.0 (M); 5.4 (F) 150 (M) 51 (F) Based on ICD-9 codes on hospital records Age, DBP, education level, smoking, and alcohol (M); age, cholesterol, SBP, smoking, BMI, alcohol and DM (F) 9
Jee et al.46 2004 Korea/Asian 22698 (100) 30–77 9 7.0 (M) 99 (M) Based on ICD-9 and 10 codes from hospitalization records and death certificates Age, HTN, DM, cholesterol, and smoking 9
Hakoda et al.47 2005 Japan/ Asian 10615 (36.4) 49 24.9 7.0 (M); 6.0 (F) 177 (M) 250 (F) Based on ICD-7 through 10 codes on death certificates Age, BMI, smoking, alcohol, SBP, cholesterol, HTN, DM, kidney disease, malignant tumor, and estimated radiation dose from the atomic bombs 9
Baibas et al.48 2005 Greece/European 1198 (42) ≥25 14 per 1 mg/1dl increase 34 (M) 33 (F) Based on ICD-9 codes on death certificates Age, body weight, smoking, alcohol, DM, SBP, cholesterol, village, TG, and educational level 9
Gerber et al.49 2006 Israel/Asian 9125 (100) 49 23 5.6 (M) 830 (M) Based on ICD-9 codes on death certificates and hospital records Age, BMI, SBP, DM, cholesterol, smoking, and LVH on EKG 9
Krishnan et al.50 2008 United States 9105 (100) 41–63 17 7.0 (M) 833 (M) Based on ICD-9 and 10 codes on death certificates Age, SBP/DBP, cholesterol, BMI, TG, serum creatinine, DM, alcohol, smoking, family history of AMI, aspirin and diuretic use 9
Strasak et al.51 (M) 2008 Austria/European 83683 (100) 41.6 12.4 6.8 (M) 844 (M) Based on ICD-9 and 10 codes on death certificates autopsy records; if available Age, BMI, cholesterol, SBP/DBP, TG, GGT, smoking, and year of examinations 9
Strasak et al.52 (F) 2008 Austria/European 28613 (0) 62.3 21 5.4 (F) 518 (F) Based on ICD-9 and 10 codes on death certificates; autopsy records; if available Age, BMI, cholesterol, SBP/DBP, TG, GGT, smoking, DM, occupational status, and year of examinations 9
Holme et al.53 2009 Sweden/European 417734 (53) 30–85 11.8 6.1 (M); 5.5 (F); per 1 mg/dl increase 12286 (M) 4888 (F) based on ICD-7, ICD-8, ICD-9, ICD-10, hospital records and the cause-of-death register Age, sex, TC, TG, HTN, DM 9
Chen et al.54 2009 China/Asian 90393 (46.3) 51.5 8.2 7.0 (M, F); per 1 mg/dl increase 286 Based on ICD-9 codes on death certificates Age, sex, BMI, cholesterol, DM, TG, HTN, smoking, and alcohol 9
Chuang et al.15 2012 China/Asian 128569 (46.6) ≥20 7.33 7.0 (M); 6.0 (F) 2049 Based on ICD-9 codes on death certificates and hospital records Age, SBP/DBP, drugs using for HTN, diuretics using, BMI, TG, TC, DM, smoking, alcohol, physical activity, and working type 9
Zalawadiya et al.16 2015 United States 11009 (unclear) 25–74 14.5 6.3 (C); per 1 mg/dl increase 458 Based on ICD-10 codes on death certificates; hospital records if available Age, sex, race, BMI, SBP, smoking, HDL, cholesterol, antihypertensive meds, CRP, eGFR 9

CHD, coronary heart disease; M. male; F, female; C, combined; CT, computer tomography; LDL, low-density lipoprotein; TC, total cholesterol; TG, triglycerides HDL, high-density lipoprotein; BMI, body mass index; HTN, hypertension; DM, diabetes mellitus; EKG, electrocardiogram; CRP, c-reactive protein; GGT, gamma-glutamyl transferase; LVH, left ventricular hypertrophy; AMI, acute myocardial infarction; SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure; eGFR, estimated glomerular filtration rate; FEV1, forced expiratory volume in one second; CABG, coronary artery bypass graft; ICD, International Classification of Diseases; ARIC, Atherosclerosis Risk in Communities.